# Clinical Trial For SARS-CoV-2 Vaccine (COVID-19)

> **NCT04582344** · PHASE3 · COMPLETED · sponsor: **Health Institutes of Turkey** · enrollment: 10214 (actual)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** CoronaVac
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT04582344
- **Lead sponsor:** Health Institutes of Turkey
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-14
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-07-27
- **Target enrollment:** 10214 (ACTUAL)
- **Last updated:** 2024-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04582344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04582344, "Clinical Trial For SARS-CoV-2 Vaccine (COVID-19)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04582344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*